Enzyme Mechanisms and Regulation – Biochemistry Study Notes

Enzyme Mechanisms and Regulation

Introduction

Enzymes are biological catalysts that accelerate chemical reactions in living organisms. Their activity is tightly regulated to ensure proper metabolic control. This study guide covers the mechanisms by which enzymes function and the various strategies cells use to regulate enzyme activity.

Oxidoreductases

Definition and Function

Oxidoreductases are enzymes that catalyze oxidation-reduction (redox) reactions, facilitating the transfer of electrons between molecules. These reactions are essential for energy production and metabolic pathways.

• Nicotinamide cofactors (NAD+/NADP+): Transfer 2 electrons (as hydride ions).

• Flavin cofactors (FAD/FMN): Transfer 1 electron (as hydrogen atoms).

• Transition metal ions: Participate in electron transfer reactions.

Key molecules:

• Nicotinic acid (Niacin, Vitamin B3)

• Nicotinamide

• Riboflavin (Vitamin B2)

• Flavin mononucleotide (FMN)

• Flavin dinucleotide (FAD)

Nicotinamide-Dependent Dehydrogenases

Mechanism and Examples

These enzymes use NAD+ or NADP+ as cofactors to catalyze redox reactions involving the transfer of hydride ions.

• Alcohol dehydrogenase: Converts acetaldehyde to ethanol in fermentation.

• Aldehyde dehydrogenase: Converts ethanol to acetaldehyde in metabolism.

Mechanism: Involves a zinc ion and key amino acid residues (e.g., Ser, His) to facilitate hydride transfer between substrate and cofactor.

Example reaction:

• Acetaldehyde + NADH + H+ → Ethanol + NAD+

Isomerases

Function and Mechanism

Isomerases catalyze the rearrangement of atoms within a molecule, converting one isomer to another. This is crucial in metabolic pathways such as glycolysis.

• Triose phosphate isomerase: Interconverts dihydroxyacetone phosphate (DHAP, a ketose) and glyceraldehyde 3-phosphate (G3P, an aldose).

Mechanism: Proceeds via an enediol intermediate, involving acid-base catalysis by active site residues.

Thermodynamics:

• $\Delta G^\circ' = -7.5\ \text{kJ/mol}$ for DHAP to G3P conversion

Ligases (e.g., Glutamine Synthetase)

Function and Mechanism

Ligases catalyze the formation of C-N, C-S, and C-O bonds, often coupling thermodynamically unfavorable reactions to ATP hydrolysis.

• Glutamine synthetase: Synthesizes glutamine from glutamate and ammonia, using ATP.

Reaction:

• Glutamate + NH3 + ATP → Glutamine + ADP + Pi

Thermodynamics:

• $\Delta G^\circ' = 14.0\ \text{kJ/mol}$ (unfavorable for glutamine synthesis)

• $\Delta G^\circ' = -30.7\ \text{kJ/mol}$ (favorable for ATP hydrolysis)

• Coupled: $\Delta G^\circ' = -16.7\ \text{kJ/mol}$ (overall favorable)

Mechanism: ATP transfers a phosphate to glutamate, forming an acyl phosphate intermediate, which is then attacked by ammonia to form glutamine.

Enzyme Activity and Regulation

General Principles

Enzyme activity is regulated to control the rate of product formation and maintain metabolic balance.

• Enzyme must be present and in active conformation.

• Substrate must be available and able to bind the active site.

• Regulation strategies include:

  • Controlling enzyme synthesis and degradation.

  • Sequestering enzyme away from substrate.

  • Modulating enzyme's ability to bind substrate (allosteric regulation, inhibition).

  • Product or substrate removal/addition to shift equilibrium.

Allosteric Regulation

Mechanism and Effects

Allosteric regulation occurs when a molecule binds to a site other than the active site, causing a conformational change that affects enzyme activity. This can be positive (activation) or negative (inhibition).

• Enzymes with multiple active sites can exhibit cooperativity, where binding at one site affects affinity at others.

• Allosteric enzymes often display sigmoidal (S-shaped) kinetics rather than Michaelis-Menten hyperbolic curves.

• Key parameters: $K_{0.5}$ (substrate concentration at half-maximal velocity), $V_{max}$ (maximum velocity).

Example: ATP (activator) and CTP (inhibitor) modulate the activity of aspartate transcarbamoylase, as shown in the provided graph.

Enzyme Inhibition

Types and Examples

Enzyme inhibition is a key regulatory mechanism and a target for drugs and toxins.

• Competitive inhibition: Inhibitor binds to active site, blocking substrate.

• Uncompetitive inhibition: Inhibitor binds only to enzyme-substrate complex.

• Mixed inhibition: Inhibitor can bind to enzyme with or without substrate.

• Irreversible inhibition: Inhibitor covalently modifies the enzyme, permanently inactivating it.

Example: Protein Kinase A is kept inactive by regulatory subunits until cAMP binds, causing a conformational change and activation.

Covalent Modification

Mechanism and Examples

Enzymes can be reversibly activated or deactivated by covalent modifications, such as phosphorylation or dephosphorylation.

• Protein kinases add phosphate groups to Ser, Thr, or Tyr residues.

• Protein phosphatases remove phosphate groups.

• Consensus sequences determine substrate specificity.

Example: Glycogen phosphorylase is regulated by phosphorylation (activation) and dephosphorylation (deactivation).

Zymogens and Proteolytic Activation

Definition and Function

Zymogens are inactive enzyme precursors that require proteolytic cleavage to become active. This mechanism is common for digestive enzymes and those involved in blood coagulation.

• Cleavage induces conformational changes, forming the active site.

• Example: Activation of proteases in the blood coagulation cascade.

Enzymes as Drug Targets

Pharmaceutical and Toxicological Applications

Many drugs and toxins act as enzyme inhibitors, affecting biochemical pathways.

• Statins: Competitive inhibitors of HMG-CoA reductase, used to lower cholesterol.

• Penicillins: Irreversible inhibitors of bacterial transpeptidase, blocking cell wall synthesis.

• Transition state analogues: Mimic the transition state of a reaction, binding tightly to the enzyme.

• Imatinib (Gleevec): Inhibits Bcr-Abl kinase, used in leukemia treatment.

• PDE5 inhibitors (e.g., sildenafil): Prevent breakdown of cGMP, leading to vasodilation.

• Remdesivir: Nucleoside analogue inhibiting viral RNA polymerase.

• Acetylcholinesterase inhibitors: Used as nerve agents and drugs for neurological conditions.

Summary Table: Enzyme Regulation Mechanisms

Regulation Mechanism	Description	Example
Allosteric Regulation	Binding of effector at non-active site alters activity	ATP/CTP regulation of aspartate transcarbamoylase
Covalent Modification	Phosphorylation/dephosphorylation changes enzyme activity	Glycogen phosphorylase
Zymogen Activation	Proteolytic cleavage activates enzyme	Digestive proteases, blood coagulation enzymes
Competitive Inhibition	Inhibitor competes with substrate for active site	Statins, penicillins
Irreversible Inhibition	Covalent modification permanently inactivates enzyme	Nerve agents, penicillins

Key Equations

• Michaelis-Menten equation: $v = \frac{V_{max}[S]}{K_M + [S]}$

• Allosteric enzyme kinetics (sigmoidal): $v = \frac{V_{max}[S]^n}{K_{0.5}^n + [S]^n}$ where n = Hill coefficient (degree of cooperativity)

Conclusion

Understanding enzyme mechanisms and regulation is fundamental to biochemistry. These principles explain how cells control metabolism and how drugs and toxins can modulate enzyme activity for therapeutic or harmful effects.